PAMELA STRANGE: Open Payments
NPI 1255854964 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,439 in 107 payments from 41 companies in 2025. Trend: 2023 $2,728 · 2024 $2,542 · 2025 $3,439
Food & beverage: $2,308Long term medical supply or device loan: $1,131
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $1,326 |
| PFIZER INC. | 9 | $205 |
| E.R. Squibb & Sons, L.L.C. | 10 | $191 |
| Genentech USA, Inc. | 6 | $146 |
| Merck Sharp & Dohme LLC | 5 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $126 |
| Fennec Pharmaceuticals, Inc. | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 4 | $94 |
| Geron Corporation | 3 | $83 |
| TerSera Therapeutics LLC | 2 | $63 |
Products named: KISQALI, OPDIVO, KEYTRUDA, XTANDI, Fyarro, RYTELO, Venclexta, ICLUSIG.
Industry payments across NC — which companies pay providers there.
